MREO

Mereo BioPharma Group PLC is a London-based biopharmaceutical company committed to developing innovative therapies for oncology and rare diseases. With a robust pipeline focused on addressing significant unmet medical needs, Mereo employs its clinical development expertise to enhance patient outcomes through targeted treatments. The company's strategic positioning within the biopharmaceutical sector, combined with its diverse portfolio, underscores its potential for sustainable growth in both UK and international markets, appealing to institutional investors seeking opportunities in transformative healthcare solutions.